Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Interstitial Lung Disease

Interstitial Lung Disease

Subtypes of Interstitial Lung Disease

Pneumoconiosis 3 Radiation pneumonitis 2 Silicosis 2 Granulomatosis with polyangiitis 1 Langerhans cell histiocytosis 1

25 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Interstitial Lung Disease

17 trials tracked for Interstitial Lung Disease: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 603 citations.

17Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 6 Other / NA 9
  1. Phase 3 Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE Completed · 603 cited
  2. Phase 4 The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 Completed · 1 cited
  3. Phase 2 Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate Completed
  4. Phase 2 A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension Completed
  5. Phase 2 Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Completed
  6. Phase 2 Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease Completed
Show 11 more trials
  1. Phase 2 Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension Completed
  2. Phase 2 Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) Completed
  3. N/A The Natural History of Small Airways Physiology in Diseased and Healthy States Completed
  4. N/A An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease Completed
  5. N/A Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease. Completed
  6. N/A Autologous Stem Cell Treatment for Chronic Lung Disease Study Completed
  7. N/A Families-At-risk for Interstitial Lung Disease Study Completed
  8. N/A Usability and Acceptability Study of the P-STEP Mobile Application Completed
  9. N/A The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease Completed
  10. N/A Assessment of Lung Movement With Computed Tomography (CT) Completed
  11. N/A A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period Completed

Showing the 17 most-cited and recently-updated of 17 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Pneumoconiosis-associated death rates among US coal workers examined from 2020 to 2023
Infectious Disease
Pneumoconiosis-associated death rates among US coal workers examined from 2020 to 2023 How many coal miners are still dying from black lung disease?
A report examined pneumoconiosis-associated death rates among coal workers in the United States from 2020 to 2023.
A new report tracks black lung deaths among U.S. coal workers from 2020 to 2023, but the key numbers on how many miners died are not yet ava…
CDC Apr 4, 2026

Questions about Interstitial Lung Disease

Will a nurse and social worker telecare team improve quality of life for my lung disease?

Yes, a nurse and social worker telecare team (ADAPT) improved quality of life, health status, depression, and anxiety in patients with interstitial lung disease in a randomized trial.

Full answer →
Does smoking increase the risk of developing interstitial lung disease in arthritis patients?

Yes, smoking increases the risk of interstitial lung disease in arthritis patients, especially those with psoriatic arthritis.

Full answer →